1-3 of 3
Kimberly B. Dahlman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition

Rebecca L. Shattuck-Brandt, Sheau-Chiann Chen, Emily Murray, Christopher Andrew Johnson, Holly Crandall, Jamye F. O'Neal, Rami Nayef Al-Rohil, Caroline A. Nebhan, Vijaya Bharti, Kimberly B. Dahlman, Gregory D. Ayers, Chi Yan, Mark C. Kelley, Rondi M. Kauffmann, Mary Hooks, Ana Grau, Douglas B. Johnson, Anna E. Vilgelm, Ann Richmond
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (14): 3803–3818.
https://doi.org/10.1158/1078-0432.CCR-19-1895
Published: 15 July 2020
View article titled, Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition
Open the PDF for Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition in another window
Includes: Supplementary data
Journal Articles

Class Matters: Sensitivity of BRAF-Mutant Melanoma to MAPK Inhibition

Douglas B. Johnson, Kimberly B. Dahlman
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (24): 6107–6109.
https://doi.org/10.1158/1078-0432.CCR-18-1795
Published: 13 December 2018
View article titled, Class Matters: Sensitivity of <em>BRAF</em>-Mutant Melanoma to MAPK Inhibition
Open the PDF for Class Matters: Sensitivity of <em>BRAF</em>-Mutant Melanoma to MAPK Inhibition in another window
Journal Articles

Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted Therapies

Catherine B. Meador, Christine M. Micheel, Mia A. Levy, Christine M. Lovly, Leora Horn, Jeremy L. Warner, Douglas B. Johnson, Zhongming Zhao, Ingrid A. Anderson, Jeffrey A. Sosman, Cindy L. Vnencak-Jones, Kimberly B. Dahlman, William Pao
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (9): 2264–2275.
https://doi.org/10.1158/1078-0432.CCR-13-1591
Published: 30 April 2014
View article titled, Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted Therapies
Open the PDF for Beyond Histology: Translating Tumor Genotypes into Clinically Effective Targeted Therapies in another window